Proliferative vitreoretinopathy : the use of adjuvant therapy in the treatment of patients and the study of clinical & biological risk factors

Proliferative vitreoretinopathy : the use of adjuvant therapy in the treatment of patients and the study of clinical & biological risk factors

Bibliographic Details
Main Author:	Asaria, Riaz Hassan Yusuf
Published:	University College London (University of London) 2002
Subjects:	617.73501
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.397951

Similar Items

Proliferative vitreoretinopathy : strategies to improve anatomical and visual outcomes
by: Banerjee, Philip James
Published: (2017)

Proliferative vitreoretinopathy
by: Mojca Globočnik-Petrovič, et al.
Published: (2005-10-01)

Molecular genetic analysis in the hereditary vitreoretinopathies
by: Meredith, Sarah P.
Published: (2010)

Proliferative vitreoretinopathy: current and emerging treatments
by: Sadaka A, et al.
Published: (2012-08-01)

Doxycycline for Proliferative Vitreoretinopathy
by: Yu-TiTeng, et al.
Published: (2018)

Proliferative Vitreoretinopathy and Genetic Profile
by: Khalil Ghasemi Falavarjani
Published: (2013-01-01)

The impact of octreotide in experimental proliferative vitreoretinopathy
by: Ozge Evren, et al.
Published: (2013-01-01)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
by: Sadaka A, et al.
Published: (2016-09-01)

The molecular genetics of two retinal dystrophies : recessive cone-rod dystrophy and dominant familial exudative vitreoretinopathy
by: Downey, Louise Mary
Published: (2003)

Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy
by: Yan-xin Ren, et al.
Published: (2018-07-01)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
by: Jose Dalma-Weiszhausz, et al.
Published: (2012-01-01)

Effect of etanercept on post-traumatic proliferative vitreoretinopathy
by: Xiao-Feng Chen, et al.
Published: (2019-05-01)

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
by: Brijesh Takkar, et al.
Published: (2017-01-01)

The role of matrix metallproteinases in pathogenesis of proliferative vitreoretinopathy
by: Shalaby, Usama A.
Published: (2001)

Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance
by: Jin Yao, et al.
Published: (2019-03-01)

Aquaporin-1 Expression in Proliferative Vitreoretinopathy and in Epiretinal Membranes
by: Elie Motulsky, et al.
Published: (2014-01-01)

Mechanisms of Inflammation in Proliferative Vitreoretinopathy: From Bench to Bedside
by: Stavros N. Moysidis, et al.
Published: (2012-01-01)

Anterior proliferative vitreoretinopathy in a patient with Coats disease
by: Satoru Kase, et al.
Published: (2018-02-01)

Outcomes of Vitrectomy in Pediatric Retinal Detachment with Proliferative Vitreoretinopathy
by: Robert Rejdak, et al.
Published: (2017-01-01)

Mechanism and effect of snake venom proteins on proliferative vitreoretinopathy
by: Chang-Hao Yang, et al.
Published: (1999)

Clinical efficacy of Conbercept combined with vitrectomy for proliferative vitreoretinopathy after choroidal detachment
by: Xiu-Zhen Shi, et al.
Published: (2018-12-01)

Key Factors to Improve the Outcome of Retinal Reattachment Surgery in Proliferative Vitreoretinopathy and Proliferative Diabetic Retinopathy
by: Svenja Deuchler, et al.
Published: (2017-01-01)

Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy
by: Yusuf Turkoz, et al.
Published: (2004-01-01)

The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
by: Salvador Pastor-Idoate, et al.
Published: (2013-01-01)

A sustained dual drug delivery system for proliferative vitreoretinopathy
by: Ying Xiao, et al.
Published: (2020-01-01)

Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.
by: Alison M Heffer, et al.
Published: (2020-01-01)

Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy: Avoiding Subretinal Persistence
by: Lizette Mowatt
Published: (2013-01-01)

Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin
by: Kumar Atul, et al.
Published: (1994-01-01)

OM-101 Decreases the Fibrotic Response Associated with Proliferative Vitreoretinopathy
by: Zeev Dvashi, et al.
Published: (2017-01-01)

Induction of proliferative vitreoretinopathy by human retinal pigment epithelial cells
by: Wong, Christian Alexander
Published: (2009)

Induction of proliferative vitreoretinopathy by human retinal pigment epithelial cells
by: Wong, Christian Alexander
Published: (2009)

Safety, pharmacokinetics, and prevention effect of intraocular crocetin in proliferative vitreoretinopathy
by: Hui-Fang Wang, et al.
Published: (2019-01-01)

Double Retinal Tamponade for Treatment of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy and Inferior Breaks
by: Mohamed Farouk Abdelkader, et al.
Published: (2020-01-01)

Testing the efficacy of GDF6 as a biological therapy for the treatment of intervertebral disc degeneration
by: Clarke, Louise
Published: (2016)

Epiretinal membrane and cystoid macular edema as predictive factors of recurrent proliferative vitreoretinopathy
by: Xu K, et al.
Published: (2017-10-01)

Anatomic and Topographic Vitreous and Vitreoretinal Interface Features in Proliferative Diabetic Vitreoretinopathy
by: N. M. Kislitsyna, et al.
Published: (2020-06-01)

Anatomical and functional outcomes of retinectomies in retinal detachments complicated by proliferative vitreoretinopathy
by: Mohammad Idrees Adhi, et al.
Published: (2017-10-01)

New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies
by: Sang Woong Moon, et al.
Published: (2018-01-01)

Radial Retinotomies with Endodiathermy for Severe Proliferative Vitreoretinopathy: Short-Term Results
by: Zhaoxin Jiang, et al.
Published: (2016-01-01)

Sustained closure of surgically repaired macular hole after proliferative vitreoretinopathy
by: Mitamura Yoshinori, et al.
Published: (2008-01-01)